Clinical relevance of conditional survival of cancer patients in Europe: Age-specific analyses of 13 cancers

Journal of Clinical Oncology

Volumn 28, Issue 15, 2010, Pages 2520-2528

  Janssen Heijnen, Maryska L G ^a   Gondos, Adam ^a   Bray, Freddie ^a   Hakulinen, Timo ^a   Brewster, David H ^a   Brenner, Hermann ^a   Coebergh, Jan Willem W ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER PATIENT; CANCER SURVIVAL; CLINICAL ASSESSMENT; COLORECTAL CANCER; ENDOMETRIUM CANCER; EPIGLOTTIS CANCER; FEMALE; GROUPS BY AGE; HUMAN; KIDNEY CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MELANOMA; NONHODGKIN LYMPHOMA; OVARY CANCER; PRIORITY JOURNAL; STOMACH CANCER; TESTIS CANCER; THYROID CANCER; UTERINE CERVIX CANCER; ADOLESCENT; AGE; AGE DISTRIBUTION; EUROPE; MIDDLE AGED; MORTALITY; NEOPLASM; PROGNOSIS; SURVIVAL;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGE FACTORS; AGED; AGED, 80 AND OVER; EUROPE; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PROGNOSIS; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 77956395773     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2009.25.9697     Document Type: Article

References (53)

1. Skuladottir H, Olsen JH: Conditional survival of patients with the four major histologic subgroups of lung cancer in Denmark. J Clin Oncol 21:3035-3040, 2003 (Pubitemid 46606282)
2. Donovan RJ, Carter OB, Byrne MJ: People's perceptions of cancer survivability: Implications for oncologists. Lancet Oncol 7:668-675, 2006 (Pubitemid 44137112)
3. Cutler SJ, Axtell LM: Partitioning of a patient population with respect to different mortality risks. J Am Stat Assoc 58:701-712, 1963
4. Dickman PW, Hakulinen T, Luostarinen T, et al: Survival of cancer patients in Finland 1955-1994. Acta Oncol 38:1-103, 1999 (suppl 12)
5. Hakulinen T, Pukkala E, Hakama M, et al: Survival of cancer patients in Finland in 1953-1974. Ann Clin Res 13:1-101, 1981 (suppl 31)
6. Merrill RM, Henson DE, Barnes M: Conditional survival among patients with carcinoma of the lung. Chest 116:697-703, 1999
7. Quaglia A, Capocaccia R, Micheli A, et al: A wide difference in cancer survival between middle aged and elderly patients in Europe. Int J Cancer 120:2196-2201, 2007 (Pubitemid 46555858)
8. Choi M, Fuller CD, Thomas CR Jr, et al: Conditional survival in ovarian cancer: Results from the SEER dataset 1988-2001. Gynecol Oncol 109:203-209, 2008
9. Henson DE, Ries LA, Carriaga MT: Conditional survival of 56,268 patients with breast cancer. Cancer 76:237-242, 1995
10. Kato I, Severson RK, Schwartz AG: Conditional median survival of patients with advanced carcinoma: Surveillance, epidemiology, and end results data. Cancer 92:2211-2219, 2001
11. Meng L, Maskarinec G, Lee J: Ethnicity and conditional breast cancer survival in Hawaii. J Clin Epidemiol 50:1289-1296, 1997 (Pubitemid 27501065)
12. Merrill RM, Henson DE, Ries LA: Conditional survival estimates in 34,963 patients with invasive carcinoma of the colon. Dis Colon Rectum 41:1097-1106, 1998
13. Punyko JA, Mertens AC, Baker KS, et al: Long-term survival probabilities for childhood rhabdomyosarcoma. A population-based evaluation. Cancer 103:1475-1483, 2005 (Pubitemid 40410745)
14. Wang SJ, Emery R, Fuller CD, et al: Conditional survival in gastric cancer: A SEER database analysis. Gastric Cancer 10:153-158, 2007 (Pubitemid 47547297)
15. Hankey BF, Steinhorn SC: Long-term patient survival for some of the more frequently occurring cancers. Cancer 50:1904-1912, 1982
16. Gamel JW, George SL, Edwards MJ, et al: The long-term clinical course of patients with cutaneous melanoma. Cancer 95:1286-1293, 2002 (Pubitemid 35013064)
17. Fuller CD, Wang SJ, Thomas CR Jr, et al: Conditional survival in head and neck squamous cell carcinoma: Results from the SEER dataset 1973- 1998. Cancer 109:1331-1343, 2007
18. Janssen-Heijnen ML, Houterman S, Lemmens VE, et al: Prognosis for long-term survivors of cancer. Ann Oncol 18:1408-1413, 2007 (Pubitemid 47305016)
19. Gondos A, Bray F, Brewster DH, et al: Recent trends in cancer survival across Europe between 2000 and 2004: A model-based period analysis from 12 cancer registries. Eur J Cancer 44:1463-1475, 2008
20. Ederer F, Heise F: Instructions to IBM 650 programmers in processing survival computations. Methodological Note No. 10. Bethesda, MD, End Results Evaluation section, National Cancer Institute, 1959
21. Brenner H, Gefeller O: An alternative approach to monitoring cancer patient survival. Cancer 78:2004-2010, 1996
22. Brenner H, Hakulinen T: Up-to-date long-term survival curves of patients with cancer by period analysis. J Clin Oncol 20:826-832, 2002 (Pubitemid 34111392)
23. Houterman S, Janssen-Heijnen ML, van de Poll-Franse LV, et al: Higher long-term cancer survival rates in southeastern Netherlands using up-to-date period analysis. Ann Oncol 17:709-712, 2006
24. Brenner H, Hakulinen T: Model based hybrid analysis of cancer patient survival. Eur J Cancer 43:921-927, 2007 (Pubitemid 46366697)
25. Brenner H, Rachet B: Hybrid analysis for up-to- date long-term survival rates in cancer registries with delayed recording of incident cases. Eur J Cancer 40:2494-2501, 2004 (Pubitemid 39424966)
26. de Vries E, Nijsten TE, Visser O, et al: Superior survival of females among 10,538 Dutch melanoma patients is independent of Breslow thickness, histologic type and tumor site. Ann Oncol 19:583-589, 2008 (Pubitemid 351325683)
27. Severi G, Plesko I, Robertson C, et al: Larynx cancer in Slovakia and the role of anatomical sub-sites. Oral Oncol 35:564-570, 1999 (Pubitemid 29506982)
28. Småstuen M, Aagnes B, Johannesen TB, et al: Long-term cancer survival: Patterns and trends in Norway 1965-2007. Oslo, Cancer Registry of Norway, 2008
29. Larsen IK, Småstuen M, Parkin DM, et al: Data quality at the Cancer Registry of Norway, in Bray F (ed): Cancer in Norway 2006 - Cancer Incidence, mortality, survival and prevalence in Norway. Oslo, Norway, Cancer Registry of Norway, 2007
30. Brenner H, Hakulinen T: Up-to-date and precise estimates of cancer patient survival: Model-based period analysis. Am J Epidemiol 164:689-696, 2006 (Pubitemid 44453498)
31. Bossard N, Velten M, Remontet L, et al: Survival of cancer patients in France: A population-based study from The Association of the French Cancer Registries (FRANCIM). Eur J Cancer 43:149-160, 2007 (Pubitemid 46054480)
32. Gloeckler Ries LA, Reichman ME, Lewis DR, et al: Cancer survival and incidence from the Surveillance, Epidemiology, and End Results (SEER) program. Oncologist 8:541-552, 2003
33. Verhoeven R, Houterman S, Kiemeney B, et al: Testicular cancer: Marked birth cohort effects on incidence and a decline in mortality in southern Netherlands since 1970. Int J Cancer 122:639-642, 2008
34. Wang SJ, Fuller CD, Thomas CR Jr: Ethnic disparities in conditional survival of patients with non-small cell lung cancer. J Thorac Oncol 2:180-190, 2007 (Pubitemid 47181322)
35. Hatteville L, Mahe C, Hill C: Prediction of the long-term survival in breast cancer patients according to the present oncological status. Stat Med 21:2345-2354, 2002
36. Hooning MJ, Aleman BM, van Rosmalen AJ, et al: Cause-specific mortality in long-term survivors of breast cancer: A 25-year follow-up study. Int J Radiat Oncol Biol Phys 64:1081-1091, 2006
37. Louwman WJ, Klokman WJ, Coebergh JW: Excess mortality from breast cancer 20 years after diagnosis when life expectancy is normal. Br J Cancer 84:700-703, 2001 (Pubitemid 32239007)
38. Woods LM, Rachet B, Cooper N, et al: Predicted trends in long-term breast cancer survival in England and Wales. Br J Cancer 96:1135-1138, 2007 (Pubitemid 46608312)
39. Zahl PH, Tretli S: Long-term survival of breast cancer in Norway by age and clinical stage. Stat Med 16:1435-1449, 1997
40. Zagars GK, Ballo MT, Lee AK, et al: Mortality after cure of testicular seminoma. J Clin Oncol 22:640-647, 2004 (Pubitemid 41095067)
41. Travis LB, Curtis RE, Stovall M, et al: Risk of leukemia following treatment for non-Hodgkin's lymphoma. J Natl Cancer Inst 86:1450-1457, 1994 (Pubitemid 24317586)
42. Clark TG, Murphy MF, Hey K, et al: Does smoking influence survival in cancer patients through effects on respiratory and vascular disease? Eur J Cancer Prev 15:87-90, 2006
43. Inghelmann R, Grande E, Francisci S, et al: National estimates of cancer patients survival in Italy: A model-based method. Tumori 91:109-115, 2005 (Pubitemid 40705080)
44. Janssen-Heijnen ML, Houterman S, Lemmens VE, et al: Prognostic impact of increasing age and co-morbidity in cancer patients: A population-based approach. Crit Rev Oncol Hematol 55:231-240, 2005 (Pubitemid 41222320)
45. Adami HO, Malker B, Holmberg L, et al: The relation between survival and age at diagnosis in breast cancer. N Engl J Med 315:559-563, 1986 (Pubitemid 16052469)
46. Louwman WJ, Voogd AC, van Dijck JA, et al: On the rising trends of incidence and prognosis for breast cancer patients diagnosed 1975-2004: A longterm population-based study in southeastern Netherlands. Cancer Causes Control 19:97-106, 2008
47. Grosclaude P, Colonna M, Hedelin G, et al: Survival of women with breast cancer in France: Variation with age, stage and treatment. Breast Cancer Res Treat 70:137-143, 2001 (Pubitemid 33139672)
48. Rosenberg J, Chia YL, Plevritis S: The effect of age, race, tumor size, tumor grade, and disease stage on invasive ductal breast cancer survival in the U.S. SEER database. Breast Cancer Res Treat 89:47-54, 2005 (Pubitemid 40228446)
49. Tai P, Cserni G, Van De Steene J, et al: Modeling the effect of age in T1-2 breast cancer using the SEER database. BMC Cancer 5:130, 2005
50. Berrino F, De Angelis R, Sant M, et al: Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: Results of the EUROCARE-4 study. Lancet Oncol 8:773-783, 2007
51. Engholm G, Kejs AM, Brewster DH, et al: Colorectal cancer survival in the Nordic countries and the United Kingdom: Excess mortality risk analysis of 5 year relative period survival in the period 1999 to 2000. Int J Cancer 121:1115-1122, 2007
52. Visser O, van Leeuwen FE: Stage-specific survival of epithelial cancers in North-Holland/Flevoland, The Netherlands. Eur J Cancer 41:2321-2330, 2005
53. van Leeuwen FE, Klokman WJ, Hagenbeek A, et al: Second cancer risk following Hodgkin's disease: A 20-year follow-up study. J Clin Oncol 12:312-325, 1994 (Pubitemid 24056405)